Based on these findings, we propose that p53 promotes elesclomol-Cu-induced cuproptosis in HCC cells via FDXR-mediated upregulation of FDX1, potentially representing a novel mechanism whereby p53 regulates cuproptosis. The gene discussed is TP53; the disease is hepatocellular carcinoma.